老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Theravance Biopharma Inc.

11.30
+0.07000.62%
盤後：11.300.00000.00%16:04 EDT
成交量：12.17萬
成交額：137.70萬
市值：5.65億
市盈率：-9.53
高：11.44
開：11.26
低：11.21
收：11.23
資料載入中...
總覽公司新聞公告
2020/09/14

重要事件披露

8-K - Current report
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/06

重要事件披露

8-K - Current report
2020/06/25

重要事件披露

8-K - Current report
2020/06/23

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/10

重要事件披露

8-K - Current report
2020/05/08

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/29

重要事件披露

8-K - Current report
2020/04/09

重要事件披露

Current report, items 8.01 and 9.01
2020/03/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/04

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/03/03

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
更多